Wednesday, February 24, 2021

Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease

Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease

from NDTV Profit - Latest https://ift.tt/2NBoYsp

No comments:

Post a Comment